is glp-1 safe for breast cancer survivors drugs linked to improved survival in large cohort study Labmate Online GLP-1 Receptor Agonists in Breast

A Review of Efficacy and Safety Data Regarding the Use of Liraglutide, a once-daily Human Glucagon-like Peptide 1 Analogue, in the Treatment of Type 2 Diabetes Mellitus

Triple Agonists (GLP-1 + GIP + Glucagon): Retatrutide, developed by Eli Lilly, takes the logic a step further by adding a glucagon receptor target

These risks underscore the importance of medical supervision, especially as use expands beyond diabetes treatment into mainstream weight-loss culture.How to Do It Safely "The solution is simple: if you are on these medications, you still have to eat, and every bite should be nutrient-dense," Stephenson said

To view or add a comment, sign in 536 followers

The conversation around it has grown, especially online, as more people taking popular weight-loss and diabetes medications realized the drugs seemed to turn off the noise

Published in Nature Medicine , the research mapped 175 health outcomes, revealing benefits for cognitive and behavioral health, including lower risks of Alzheimers, dementia, seizures, addiction, suicidal thoughts, and certain psychiatric disorders